ScoreWhy is Diamyd Medical AB ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.98%
EBIT Growth (5y)
-331.64%
EBIT to Interest (avg)
-73.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.84
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
11.49%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.07
EV to EBIT
-8.73
EV to EBITDA
-9.04
EV to Capital Employed
38.66
EV to Sales
1681.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-443.04%
ROE (Latest)
-78.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(HY)
At SEK 0.17 MM has Grown at 95.35%
CASH AND EQV(HY)
Highest at SEK 536.83 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -112.92 %
-26What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at SEK -190.85 MM
ROCE(HY)
Lowest at -97.13%
PRE-TAX PROFIT(Q)
Lowest at SEK -127.06 MM
NET PROFIT(Q)
Lowest at SEK -127.06 MM
RAW MATERIAL COST(Y)
Grown by 3,196,377% (YoY
OPERATING PROFIT(Q)
Lowest at SEK -125.33 MM
EPS(Q)
Lowest at SEK -0.84
Here's what is working for Diamyd Medical AB
Net Sales
At SEK 0.17 MM has Grown at 95.35%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (SEK MM)
Cash and Eqv
Highest at SEK 536.83 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -112.92 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Diamyd Medical AB
Pre-Tax Profit
At SEK -127.06 MM has Fallen at -192.94%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -127.06 MM has Fallen at -192.94%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Operating Cash Flow
Lowest at SEK -190.85 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Pre-Tax Profit
Lowest at SEK -127.06 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (SEK MM)
Net Profit
Lowest at SEK -127.06 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Operating Profit
Lowest at SEK -125.33 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (SEK MM)
EPS
Lowest at SEK -0.84
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (SEK)
Raw Material Cost
Grown by 3,196,377% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
